vs

Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.

CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $9.2M, roughly 1.5× Cytosorbents Corp). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs 0.9%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs 1.2%).

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

CBFV vs CTSO — Head-to-Head

Bigger by revenue
CBFV
CBFV
1.5× larger
CBFV
$13.8M
$9.2M
CTSO
Growing faster (revenue YoY)
CBFV
CBFV
+19.0% gap
CBFV
19.9%
0.9%
CTSO
More free cash flow
CBFV
CBFV
$22.1M more FCF
CBFV
$17.2M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
CTSO
CTSO
Annualised
CTSO
1.3%
1.2%
CBFV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBFV
CBFV
CTSO
CTSO
Revenue
$13.8M
$9.2M
Net Profit
$-5.5M
Gross Margin
73.7%
Operating Margin
38.1%
-47.5%
Net Margin
-59.5%
Revenue YoY
19.9%
0.9%
Net Profit YoY
27.4%
EPS (diluted)
$0.90
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBFV
CBFV
CTSO
CTSO
Q4 25
$13.8M
$9.2M
Q3 25
$2.4M
$9.5M
Q2 25
$13.5M
$9.6M
Q1 25
$12.1M
$8.7M
Q4 24
$13.2M
$9.2M
Q3 24
$12.7M
$8.6M
Q2 24
$12.2M
$8.8M
Q1 24
$13.5M
$9.0M
Net Profit
CBFV
CBFV
CTSO
CTSO
Q4 25
$-5.5M
Q3 25
$-5.7M
$-3.2M
Q2 25
$3.9M
$1.9M
Q1 25
$1.9M
$-1.5M
Q4 24
$-7.6M
Q3 24
$3.2M
$-2.8M
Q2 24
$2.6M
$-4.3M
Q1 24
$4.2M
$-6.1M
Gross Margin
CBFV
CBFV
CTSO
CTSO
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
CBFV
CBFV
CTSO
CTSO
Q4 25
38.1%
-47.5%
Q3 25
-289.8%
-30.2%
Q2 25
35.0%
-37.6%
Q1 25
19.3%
-44.5%
Q4 24
23.1%
-37.1%
Q3 24
31.2%
-56.1%
Q2 24
26.4%
-40.4%
Q1 24
37.9%
-51.8%
Net Margin
CBFV
CBFV
CTSO
CTSO
Q4 25
-59.5%
Q3 25
-235.2%
-33.4%
Q2 25
29.3%
20.2%
Q1 25
15.8%
-16.9%
Q4 24
-82.7%
Q3 24
25.3%
-32.1%
Q2 24
21.8%
-48.6%
Q1 24
31.1%
-67.7%
EPS (diluted)
CBFV
CBFV
CTSO
CTSO
Q4 25
$0.90
$-0.09
Q3 25
$-1.07
$-0.05
Q2 25
$0.74
$0.03
Q1 25
$0.35
$-0.02
Q4 24
$0.45
$-0.14
Q3 24
$0.60
$-0.05
Q2 24
$0.51
$-0.08
Q1 24
$0.82
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBFV
CBFV
CTSO
CTSO
Cash + ST InvestmentsLiquidity on hand
$31.7M
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.5M
$5.9M
Total Assets
$1.5B
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBFV
CBFV
CTSO
CTSO
Q4 25
$31.7M
$6.2M
Q3 25
$55.9M
$7.5M
Q2 25
$64.5M
$10.2M
Q1 25
$61.3M
$11.6M
Q4 24
$49.6M
$3.3M
Q3 24
$147.3M
$5.7M
Q2 24
$142.6M
$8.5M
Q1 24
$73.7M
$8.6M
Total Debt
CBFV
CBFV
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CBFV
CBFV
CTSO
CTSO
Q4 25
$157.5M
$5.9M
Q3 25
$152.5M
$9.0M
Q2 25
$148.4M
$11.6M
Q1 25
$148.3M
$14.5M
Q4 24
$147.4M
$11.1M
Q3 24
$149.1M
$13.4M
Q2 24
$142.9M
$17.4M
Q1 24
$141.6M
$19.6M
Total Assets
CBFV
CBFV
CTSO
CTSO
Q4 25
$1.5B
$44.2M
Q3 25
$1.5B
$45.8M
Q2 25
$1.5B
$48.0M
Q1 25
$1.5B
$50.8M
Q4 24
$1.5B
$47.4M
Q3 24
$1.6B
$47.8M
Q2 24
$1.6B
$53.4M
Q1 24
$1.5B
$47.1M
Debt / Equity
CBFV
CBFV
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBFV
CBFV
CTSO
CTSO
Operating Cash FlowLast quarter
$17.8M
$-4.8M
Free Cash FlowOCF − Capex
$17.2M
$-4.9M
FCF MarginFCF / Revenue
124.1%
-53.4%
Capex IntensityCapex / Revenue
4.7%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$29.5M
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBFV
CBFV
CTSO
CTSO
Q4 25
$17.8M
$-4.8M
Q3 25
$4.6M
$-2.6M
Q2 25
$4.1M
$-1.5M
Q1 25
$4.0M
$-3.5M
Q4 24
$6.8M
$-2.3M
Q3 24
$3.1M
$-2.5M
Q2 24
$-1.2M
$-4.8M
Q1 24
$3.3M
$-4.8M
Free Cash Flow
CBFV
CBFV
CTSO
CTSO
Q4 25
$17.2M
$-4.9M
Q3 25
$4.5M
$-2.6M
Q2 25
$3.9M
$-1.5M
Q1 25
$3.9M
$-3.5M
Q4 24
$3.4M
$-2.4M
Q3 24
$2.2M
$-2.6M
Q2 24
$-2.4M
$-4.8M
Q1 24
$2.3M
$-4.9M
FCF Margin
CBFV
CBFV
CTSO
CTSO
Q4 25
124.1%
-53.4%
Q3 25
186.5%
-27.3%
Q2 25
28.8%
-16.1%
Q1 25
32.5%
-39.7%
Q4 24
26.0%
-26.3%
Q3 24
17.4%
-30.4%
Q2 24
-19.6%
-54.4%
Q1 24
17.0%
-54.2%
Capex Intensity
CBFV
CBFV
CTSO
CTSO
Q4 25
4.7%
1.2%
Q3 25
4.3%
0.2%
Q2 25
1.9%
0.4%
Q1 25
0.8%
0.0%
Q4 24
25.1%
0.8%
Q3 24
6.7%
1.8%
Q2 24
10.0%
0.2%
Q1 24
7.2%
0.5%
Cash Conversion
CBFV
CBFV
CTSO
CTSO
Q4 25
Q3 25
Q2 25
1.05×
-0.78×
Q1 25
2.11×
Q4 24
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBFV
CBFV

Segment breakdown not available.

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

Related Comparisons